Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00325936Phase 4Completed
A Phase 4 trial of cilnidipine in hypertension (HTN), metabolic syndrome, sponsored by Boryung. Started Jul 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00325936.